Neurizon Therapeutics Limited (ASX: NUZ & NUZOA) ("Neurizon" or "the Company"), a clinical-stage biotech company advancing ...

The Food and Drug Administration (FDA) is proposing the removal from the market of a common ingredient found in most oral ...

J&J’s filing is based on results from the phase 3 AQUILA trial. Among 390 patients with high-risk smoldering multiple myeloma ...

The Consumer Healthcare Products Association, which represents manufacturers and marketers of over-the-counter medicines, ...

The US Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular ...

Modern pharmaceuticals have revolutionised disease prevention and treatment. But eventually, the chemicals can end up in rivers, oceans and soils.

The FDA says oral phenylephrine, used in many over-the-counter cough and cold medicines, "is not effective as a nasal ...

An extensive review determined that the ingredient, oral phenylephrine, doesn’t actually relieve nasal congestion.

The longtime anti-vaccine activist may be tapped as a White House czar, overseeing agencies responsible for vaccine approvals ...

In this article, we take a look at five biotech companies developing potentially transformative medicines to treat cystic ...

There are an average of 49 drug poisoning deaths weekly involving opiates - such as heroin, oxycodone, fentanyl and including ...